Including Oral-Only Drugs in the ESRD PPS Bundled Payment
This document summarizes the current policy that has been established in
rulemaking regarding the incorporation of oral‐only phosphate binders into
the ESRD prospective payment system effective 1/1/2025, and provides key
operational information (specifically HCPCS codes and key timelines for
upcoming data submission deadlines).
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 29, 2024
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.